熱門資訊> 正文
据称,Blackstone、TPG即将收购Hologic超过170亿美元
2025-10-19 02:41
- Private equity firms Blackstone (NYSE:BX) and TPG (NASDAQ:TPG) are in late-stage talks to acquire Hologic (NASDAQ:HOLX) in a transaction that could value the cancer test maker at more than $17B, including debt, Bloomberg News reported, citing people familiar with the matter.
- The companies are currently negotiating a price target of over $75 per share, the people said, adding that a deal could be announced in the coming days.
- Shares of Hologic (NASDAQ:HOLX) closed higher on Thursday after 9fin reported about a $9B financing arrangement to fund the duo’s plans to acquire the Marlborough, Massachusetts-based medical device maker. The stock added another ~2% on Friday and ~6% in the post-market after Bloomberg reported about the potential deal.
- A final agreement has yet to be reached, and the talks could still end prematurely, the people said.
More on Hologic, Blackstone, etc.
- Blackstone Is A Sell Again, At Today's Lofty Valuation
- Blackstone Is A Conundrum (Technical Analysis)
- Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Hologic ticks higher amid report on financing for potential takeover
- Blackstone launches business unit focusing on defined contribution plans
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。